443 related articles for article (PubMed ID: 26505803)
21. American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients.
Shields CL; Kaliki S; Furuta M; Fulco E; Alarcon C; Shields JA
Ophthalmology; 2013 Oct; 120(10):2066-71. PubMed ID: 23664467
[TBL] [Abstract][Full Text] [Related]
22. Metastasis from uveal melanoma associated with congenital ocular melanocytosis: a matched study.
Mashayekhi A; Kaliki S; Walker B; Park C; Sinha N; Kremer FZ; Shields CL; Shields JA
Ophthalmology; 2013 Jul; 120(7):1465-8. PubMed ID: 23522968
[TBL] [Abstract][Full Text] [Related]
23. Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor Origin.
Shields CL; Welch RJ; Malik K; Acaba-Berrocal LA; Selzer EB; Newman JH; Mayro EL; Constantinescu AB; Spencer MA; McGarrey MP; Knapp AN; Graf AE; Altman AJ; Considine SP; Shields JA
Middle East Afr J Ophthalmol; 2018; 25(2):81-90. PubMed ID: 30122853
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.
Valsecchi ME; Orloff M; Sato R; Chervoneva I; Shields CL; Shields JA; Mastrangelo MJ; Sato T
Ophthalmology; 2018 Feb; 125(2):210-217. PubMed ID: 28935400
[TBL] [Abstract][Full Text] [Related]
25. Sex Disparity in Survival of Patients With Uveal Melanoma: Better Survival Rates in Women Than in Men in South Korea.
Park SJ; Oh CM; Yeon B; Cho H; Park KH
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1909-1915. PubMed ID: 28362882
[TBL] [Abstract][Full Text] [Related]
26. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
Szalai E; Wells JR; Ward L; Grossniklaus HE
Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
[TBL] [Abstract][Full Text] [Related]
27. Local Failure After Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors, and Management.
Bellerive C; Aziz HA; Bena J; Wilkinson A; Suh JH; Plesec T; Singh AD
Am J Ophthalmol; 2017 May; 177():9-16. PubMed ID: 28163118
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
[TBL] [Abstract][Full Text] [Related]
29. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
Frenkel S; Hendler K; Pe'er J
Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
[TBL] [Abstract][Full Text] [Related]
30. Prospective study of surveillance testing for metastasis in 100 high-risk uveal melanoma patients.
Piperno-Neumann S; Servois V; Mariani P; Plancher C; Lévy-Gabriel C; Lumbroso-Le Rouic L; Couturier J; Asselain B; Desjardins L; Cassoux N
J Fr Ophtalmol; 2015 Jun; 38(6):526-34. PubMed ID: 25978872
[TBL] [Abstract][Full Text] [Related]
31. Metastatic melanoma in the eye and orbit.
Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
[TBL] [Abstract][Full Text] [Related]
32. Posterior uveal melanoma incidence and survival by AJCC tumour size in a 70-year nationwide cohort.
Smidt-Nielsen I; Bagger M; Heegaard S; Andersen KK; Kiilgaard JF
Acta Ophthalmol; 2021 Dec; 99(8):e1474-e1482. PubMed ID: 33738986
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma.
Yousef YA; Finger PT
Arch Ophthalmol; 2012 May; 130(5):599-606. PubMed ID: 22652846
[TBL] [Abstract][Full Text] [Related]
34. Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients.
Bol KF; Mensink HW; Aarntzen EH; Schreibelt G; Keunen JE; Coulie PG; de Klein A; Punt CJ; Paridaens D; Figdor CG; de Vries IJ
Am J Ophthalmol; 2014 Nov; 158(5):939-47. PubMed ID: 25038326
[TBL] [Abstract][Full Text] [Related]
35. Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.
Shields CL; Di Nicola M; Bekerman VP; Kaliki S; Alarcon C; Fulco E; Shields JA
Ophthalmology; 2018 Jun; 125(6):913-923. PubMed ID: 29342436
[TBL] [Abstract][Full Text] [Related]
36. Conditional Survival in Uveal Melanoma.
Zabor EC; Radivoyevitch T; Singh AD; Kilic E; de Klein JEMM; Kalirai H; Coupland SE
Ophthalmol Retina; 2021 Jun; 5(6):536-542. PubMed ID: 32979556
[TBL] [Abstract][Full Text] [Related]
37. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
38. Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma.
Harbour JW; Char DH; Kroll S; Quivey JM; Castro J
Ophthalmology; 1997 Nov; 104(11):1785-92; discussion 1792-3. PubMed ID: 9373108
[TBL] [Abstract][Full Text] [Related]
39. Association of Radial Margin Positivity With Colon Cancer.
Amri R; Bordeianou LG; Sylla P; Berger DL
JAMA Surg; 2015 Sep; 150(9):890-8. PubMed ID: 26132363
[TBL] [Abstract][Full Text] [Related]
40. Gene Expression Profiling Prognostication of Posterior Uveal Melanoma: Does Size Matter?
Binkley EM; Bena JF; Davanzo JM; Hinz C; Boldt HC; Singh AD
Ophthalmol Retina; 2020 Jun; 4(6):620-629. PubMed ID: 32081600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
